Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, could downregulate GPR32 expression by altering the chromatin structure around its gene, leading to decreased transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine may reduce GPR32 gene methylation, potentially decreasing its mRNA synthesis and subsequent protein levels. | ||||||
ICI 182,780 | 129453-61-8 | sc-203435 sc-203435A | 1 mg 10 mg | $83.00 $187.00 | 34 | |
ICI 182,780 (Fulvestrant), though an estrogen receptor antagonist, could hypothetically decrease GPR32 expression by disrupting potential estrogen receptor-mediated stabilization of GPR32 mRNA. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could inhibit the mTOR pathway, which may be necessary for GPR32 protein translation, thus leading to reduced protein levels. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059, by inhibiting MEK, could lead to decreased ERK phosphorylation, which may be involved in the transcriptional repression of GPR32. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580, through inhibition of p38 MAPK, could decrease GPR32 expression by hindering p38 MAPK-mediated transcriptional activation of the GPR32 gene. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002, by blocking PI3K, could reduce the activation of AKT, potentially leading to a decrease in GPR32 expression if PI3K/AKT signaling controls GPR32 gene transcription. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 may decrease GPR32 expression by inhibiting JNK, which could be involved in transcriptional activation processes for the GPR32 gene. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Inhibiting the Wnt/β-catenin pathway with Wnt-C59 could lead to decreased transcriptional activation of GPR32 if its expression is Wnt pathway-dependent. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT may reduce GPR32 expression by inhibiting the γ-secretase enzyme, potentially decreasing Notch intracellular domain (NICD) levels and affecting transcription factors that control GPR32 gene expression. | ||||||